$1.38
arrow_drop_down2.12%Key Stats | |
---|---|
Open | $1.48 |
Prev. Close | $1.41 |
EPS | -1.86 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $14.37M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 1.38 | 1.48 |
52 Week Range | 1.20 | 3.25 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.86 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session